Third Dose of the BNT162b2 Vaccine Results in Sustained High Levels of Neutralizing Antibodies Against SARS-CoV-2 at 6 Months Following Vaccination in Healthy Individuals

類似資料

• Comparison of Neutralizing Antibody Responses at 6 Months Post Vaccination with BNT162b2 and AZD1222
  著者:: Evangelos Terpos, 等
  出版事項: (2022-02-01)
• Robust Neutralizing Antibody Responses 6 Months Post Vaccination with BNT162b2: A Prospective Study in 308 Healthy Individuals
  著者:: Evangelos Terpos, 等
  出版事項: (2021-10-01)
• Kinetics of Anti-SARS-CoV-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health Workers
  著者:: Evangelos Terpos, 等
  出版事項: (2021-07-01)
• Predictive Factors for Neutralizing Antibody Levels Nine Months after Full Vaccination with BNT162b2: Results of a Machine Learning Analysis
  著者:: Dimitris Papadopoulos, 等
  出版事項: (2022-01-01)
• Second Booster BNT162b2 Restores SARS-CoV-2 Humoral Response in Patients With Multiple Myeloma, Excluding Those Under Anti-BCMA Therapy
  著者:: Ioannis Ntanasis-Stathopoulos, 等
  出版事項: (2022-08-01)